Navigation Links
PharmAthene Reports Third Quarter 2013 Financial And Operational Results
Date:11/7/2013

matters related thereto; failure of either party to meet the conditions to closing of the transaction; delays in completing the transaction and the risk that the transaction may not be completed at all; failure to realize the anticipated benefits from the transaction or delay in realization thereof; the businesses of PharmAthene and Theraclone may not be combined successfully, or such combination may take longer, be more difficult, time-consuming or costly to accomplish than expected; operating costs and business disruption during the pendency of and following the transaction, including adverse effects on employee retention and on business relationships with third parties; the combined company's need for and ability to obtain additional financing; risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the combined company's product candidates; unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the combined company's development programs; the award of government contracts to competitors; unforeseen safety issues; unexpected determinations that these product candidates prove not to be effective or capable of being marketed as products; as well as risks detailed from time to time in PharmAthene's annual report on Form 10-K and quarterly reports on Form 10-Q under the caption "Risk Factors" and in its other reports filed with the SEC. Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.

-- Tables Follow –PHARMATHENE, INC.CONDENSED CONSOLIDATED BALANCE SHEETSSeptember 30,December 31,20132012 (Unaudited) ASSETSCurrent assets:Cash and cash equivalents

$
5,943,399$
2,701,517Billed accounts receivable

-2,432,641
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
2. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
3. PharmAthene Reports First Quarter 2013 Financial And Operational Results
4. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
5. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
6. Pharmacyclics Reports Third Quarter 2013 Results
7. CareFusion Reports First Quarter Fiscal 2014 Results
8. Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2013
9. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
10. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
11. ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Solutions announced the expansion of its operations in ... for mid-March and access for customers is expected shortly ... and located adjacent to the current office, the new ... engineering team and allow Finesse to bring on more ...
(Date:2/26/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... the t:slim® and t:flex™ Insulin Pumps, today announced the ... of its common stock at a price to the ... Tandem from this offering are expected to be $56.3 ... estimated offering expenses payable by Tandem. All of the ...
(Date:2/26/2015)... 26, 2015  Today the National Safety Council ... and physical side effects of pain medications ... as Vicodin and Oxycontin, are safer options than over-the-counter ... prescription painkillers than on heroin and cocaine combined," said ... NSC. "Yet, these medications are marketed as the Cadillac ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... , PARIS , Feb. 9 ... today that it has successfully completed its tender offer for all ... , The tender offer and withdrawal rights expired at 12:00 midnight, ... .  The depositary for the tender offer has advised sanofi-aventis that, ...
... EAST BRUNSWICK, N.J. , Feb. 8 Savient Pharmaceuticals, ... release financial results for the fourth quarter and year-end 2009 following ... . , Paul Hamelin , President and David Gionco, ... community conference call beginning at 10:00 a.m. Eastern Time ...
Cached Medicine Technology:Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2
(Date:2/27/2015)... 27, 2015 Insight Accelerator Labs ... advance the development of an in-line urine flow ... is being developed in direct response to current ... accuracy and error margins with potentially grave consequences. ... measurement and provide trending data analysis to signal ...
(Date:2/27/2015)... 27, 2015 The Lymphoma Research Foundation ... to funding innovative lymphoma research and serving the lymphoma ... initiatives and patient services – is continuing to make ... to the greater Miami area to host Swirl, A ... in Miami Beach on Thursday, March 26, 2015. This ...
(Date:2/27/2015)... 27, 2015 Muscular Dystrophy Association ... Engineering at Duke University, recently announced a potentially ... young men with Duchenne muscular dystrophy (DMD). The ... and Gersbach will discuss their implications at MDA's ... in Washington, D.C. , Background: Gersbach and ...
(Date:2/27/2015)... 27, 2015 With cases of head ... concerned parents look to school administrations to help prevent the ... head lice is a common parasite that passes easily among ... causing parents and teachers significant distress. , The answer ... at the school. This would allow parents and teachers to ...
(Date:2/27/2015)... 2015 BaliniSports is expanding its presence ... fitness social platform FITMOO. The collaboration is aimed to ... philosophy behind BaliniSports. Users of FITMOO will be able ... and discover apparel that will enhance their workouts. , ... friendly and socially conscious methods to produce its line ...
Breaking Medicine News(10 mins):Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:South Florida Parents Put Pressure on Schools to Perform Lice Screenings to Prevent Spread of Lice According to One Miami Lice Removal Company Called Lice Troopers 2Health News:BaliniSports Announces Collaboration with FITMOO 2
... Scientists at the University of Liverpool have identified high levels ... may suggest why they live longer than other rodents and ... recently generated the first whole-genome sequencing data of the naked ... years and is resistant to cancer - to understand its ...
... , THURSDAY, Nov. 3 (HealthDay News) --,When an ... can suffer fatal injuries, a new report suggests. That,s ... associated with these natural disasters occur when bridges and roads ... is disrupted, according to a group of Boston researchers who ...
... News) -- Smokers are more likely to kick the habit ... processes emotions was damaged by the stroke, researchers say. ... smoking before they had a stroke were much more likely ... about quitting. These findings may lead to new ways ...
... , THURSDAY, Nov. 3 (HealthDay News) -- A new ... calls into question the widespread practice of classifying children ... and their IQ scores, researchers report. ... many school systems in the United States to determine ...
... PHILADELPHIA - A research group at the Perelman School ... John Lynch, MD, PhD, assistant professor of Medicine in ... Institute (NCI) grant to establish a Barrett,s esophagus translational ... Timothy Wang) and the Mayo Clinic (led by Dr. ...
... federal government is investing billions of dollars to encourage ... technology so that all Americans can benefit from the ... about potential harm are emerging as providers increasingly rely ... information technologies to deliver care. ,HEALTH IT ...
Cached Medicine News:Health News:Scientists identify genes that may signal long life in naked mole-rats 2Health News:Earthquakes Put Millions of Lives, Major Cities at Risk 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Study Finds No Link Between Dyslexia and IQ 2Health News:Penn collaborates on $8 million Barrett's esophagus research network 2Health News:Penn collaborates on $8 million Barrett's esophagus research network 3
... The IMMULITE 1000 immunoassay system features ... reliability, robust hardware and excellent assay ... reagents and accommodates onboard dilutions, positive ... , Worldwide, IMMULITE 1000 (and its ...
... The AIA-1800 is the newest and most ... Inc. The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... 250 is a flexible system ... multiple environments small hospitals, ... and satellite locations. The Vitros ... and can be automated or ...
Medicine Products: